drug
0
Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
0

Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...

0
‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist
0

That is the title of a KFF article published last week. Results are based on KFF. 2024 Employer Health Benefits Survey. ...

0
Impact of genericization on drug prices and treatment value across 8 countries – Healthcare Economist
0

An interesting study of Miquel Serra-Burriel et al. (2024) It examines the impact of genericisation on drug prices in ...

0
Two Years of Lower Prescription Drug Costs
0

Today marks the second anniversary of the Inflation Reduction Act, and it's clear how much progress the Biden-Harris Administration has made since then. ...

0
Medicare Drug Price Negotiation leads to 38% to 79% price decrease – Healthcare Economist
0

Medicare drug price negotiation is here. Medicare's maximum fair prices (MFPs) result in discounts of between 38% and 79%. In fact, the actual discounts ...

0
Martha’s Story: Capping Medicare Out-of-Pocket Prescription Drug Costs
0

I was diagnosed with leukemia in 2019. My leukemia is considered a more aggressive type, but I am very lucky that there are new medications that do ...

0
Drug shortages in the US – Healthcare Economist
0

The good news: Drug shortages in 2023 have declined in the United States from their recent peak between 2010 and 2012. ...

0
Time is money in drug development – Healthcare Economist
0

Delays in drug approval cost pharmaceutical companies money. These costs include both lost sales and the additional cost if clinical trials need to last ...

0
Recent Medicare attempts to lower drug prices (beyond IRA) – Healthcare Economist
0

Recently, the Inflation Reduction Act (IRA) is receiving a lot of attention, particularly for its provision that allows CMS to begin price negotiations for ...

0
A primer on brand-name prescription drug contracting – Healthcare Economist
0

The above is the title of a useful manual of Kenney and Keast (2024). Below I summarize some key points. Provide an overview of pharmacy contracts ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart